Effects of voriconazole on Candida glabratain vitro
Open Access
- 1 July 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 44 (1) , 109-112
- https://doi.org/10.1093/jac/44.1.109
Abstract
The effects of voriconazole on the growth, morphology and lipids of Candida glabratawere studied. MIC data showed that voriconazole was up to 32- to 64-fold more active than fluconazole in its ability to inhibit various C. glabrata strains. Voriconazole inhibited the growth of C. glabrata in a dose-dependent fashion. Electron microscope examination showed that voriconazole treatment affected the external and internal morphology of C. glabrata. Treatment of C. glabrata with voriconazole inhibited ergosterol synthesis and led to accumulation of methylated sterols. In contrast, no significant difference in phospholipid composition was observed between treated and untreated cells.Keywords
This publication has 4 references indexed in Scilit:
- A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida kruseiAntimicrobial Agents and Chemotherapy, 1997
- Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida speciesAntimicrobial Agents and Chemotherapy, 1997
- The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistanceThe American Journal of Medicine, 1996
- Antimycotic effects of octenidine and pirtenidineJournal of Antimicrobial Chemotherapy, 1990